These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28034718)

  • 1. Control of adipogenesis by oxylipins, GPCRs and PPARs.
    Barquissau V; Ghandour RA; Ailhaud G; Klingenspor M; Langin D; Amri EZ; Pisani DF
    Biochimie; 2017 May; 136():3-11. PubMed ID: 28034718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet Supplementation in ω3 Polyunsaturated Fatty Acid Favors an Anti-Inflammatory Basal Environment in Mouse Adipose Tissue.
    Colson C; Ghandour RA; Dufies O; Rekima S; Loubat A; Munro P; Boyer L; Pisani DF
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
    Hummasti S; Tontonoz P
    Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PPARs-mediated intracellular signal transduction].
    Fujii H
    Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging.
    Echeverría F; Ortiz M; Valenzuela R; Videla LA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Nov; 114():28-34. PubMed ID: 27926461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
    Viana Abranches M; Esteves de Oliveira FC; Bressan J
    Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PPARs and cell-cell or cell-extracellular matrix interactions].
    Murad H; Fiatte C; Brunner E; Huin-Schohn C; Schohn H; Bécuwe P; Domenjoud L; Dauça M
    Med Sci (Paris); 2007 May; 23(5):515-8. PubMed ID: 17502068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
    Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
    Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.
    Froment P; Gizard F; Defever D; Staels B; Dupont J; Monget P
    J Endocrinol; 2006 May; 189(2):199-209. PubMed ID: 16648288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
    Takahashi N; Goto T; Kusudo T; Moriyama T; Kawada T
    Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Be fit or be sick: peroxisome proliferator-activated receptors are down the road.
    Desvergne B; Michalik L; Wahli W
    Mol Endocrinol; 2004 Jun; 18(6):1321-32. PubMed ID: 15087471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.
    Michalik L; Wahli W
    Biochim Biophys Acta; 2007 Aug; 1771(8):991-8. PubMed ID: 17400022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR receptor activation: Experimental studies on cardiac structure and function.
    Bishop-Bailey D
    Curr Opin Investig Drugs; 2010 Mar; 11(3):283-8. PubMed ID: 20178041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors.
    Mandard S; Stienstra R; Escher P; Tan NS; Kim I; Gonzalez FJ; Wahli W; Desvergne B; Müller M; Kersten S
    Cell Mol Life Sci; 2007 May; 64(9):1145-57. PubMed ID: 17437057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.